Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Cigall Kadoch

Dana Farber Cancer Inst, Department: Na

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Foghorn Therapeutics

Disclosed Value
Listed Reason
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)

please see attachment

Listed Research Project
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer

PROJECT NARRATIVE While immunotherapy has transformed treatment for numerous malignancies, this benefit has not been fully realized in prostate cancer. To overcome this critical challenge, we have created a multidisciplinary and highly collaborative program to define immune cell composition, states, and interactions that mediate selective immunotherapy response; prove that specific tumor-intrinsic somatic mutations in chromatin regulators drive immunotherapeutic responses in a heterogeneous prostate cancer population; and identify combination treatment strategies to boost responses in aPD-1 non-responsive PCa. Overall, this program will conduct systematic how promote and comprehensive investigations of tumor cells evade the immune system, and anti-tumor immune responses. host immune cell-prostate cancer cell interactions to define identify strategies to reprogram immune and tumor cells to

Filed on September 28, 2018.

Tell us what you know about Cigall Kadoch's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Cigall Kadoch Dana Farber Cancer Inst Conflict of Interest Foghorn Therapeutics Value cannot be readily determined
Cigall Kadoch Dana Farber Cancer Inst Conflict of Interest Foghorn Therapeutics $0 - $4,999
Cigall Kadoch Dana Farber Cancer Inst Conflict of Interest Foghorn Therapeutics, Inc. Value cannot be readily determined
Cigall Kadoch Dana Farber Cancer Inst Conflict of Interest Foghorn Therapeutics $200,000 - $249,999
Cigall Kadoch Dana Farber Cancer Inst Conflict of Interest Foghorn Therapeutics $150,000 - $199,999
Cigall Kadoch Sarc Conflict of Interest Dana-Farber Cancer Institute $150,000 - $199,999
Cigall Kadoch Beth Israel Deaconess Medical Center Conflict of Interest Foghorn Therapeutics Value cannot be readily determined
Cigall Kadoch Dana Farber Cancer Inst Conflict of Interest Foghorn Therapeutics, Inc. $150,000 - $199,999
Cigall Kadoch Dana Farber Cancer Inst Conflict of Interest Foghorn Therapeutics $0 - $4,999
Cigall Kadoch Dana Farber Cancer Inst Conflict of Interest Foghorn Therapeutics Value cannot be readily determined
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page